Research and Development

This unique technology is registered with the FDA in the US as a Class 1 Device, and has been granted three distinct U.S. patents as a low-frequency acoustic methodology for pain application.

Sonix Health is currently conducting multiple studies on diabetic neuropathy and rheumatoid arthritis.

University pilot studies indicate over 85% of Medsonix therapy recipient’s experienced symptomatic improvement and no negative side effects, with only one application.

Below are some examples of research into low frequency sound wave application.

University of Nevada: The effects of a low frequency acoustic waveform on peripheral vascular disease: a
pilot study

Journal of Musculoskeletal Disorders and Treatment

DISCLAIMER: The content provided is for general information purposes only. It is not intended as medical advice. Under no circumstances does Sonix Health, Sonix Health Distributing or any of its affiliates recommend a particular treatment for specific individuals and in all cases recommend consultation with a physician before pursuing any course of treatment. 

Proud sponsor of Beyond Blue